42 minutes ago
A panelist discusses how the current goal in managing chronic spontaneous urticaria (CSU) is complete symptom control, balanced with patient preferences, while highlighting the future promise of disease-modifying therapies that could shorten disease duration and shift care from long-term suppression to potential remission.
47 minutes ago
5 FDA updates in psychiatry from the first half of 2025, plus other pipeline developments in psychiatry for depression, schizophrenia, and OUD.
47 minutes ago
Panelists discuss how eosinophilic esophagitis (EoE) diagnosis requires both clinical symptoms and histologic confirmation through upper endoscopy with biopsies showing 15 or more eosinophils per high-power field, while identifying key endoscopic features such as edema, rings, exudates, furrows, and strictures, though diagnostic challenges include biopsy variability and parental recognition of symptoms in pediatric cases.
47 minutes ago
Panelists discuss how emerging treatment modalities including digital therapeutics and novel pharmaceutical agents represent an exciting new frontier that could elevate the standard of care for schizophrenia patients when combined with traditional approaches.
47 minutes ago
Panelists discuss how distinguishing eosinophilic esophagitis (EoE) from other conditions such as gastroesophageal reflux disease requires careful clinical context evaluation. They note that not all esophageal eosinophilia above 15 per high-power field indicates EoE and emphasize the importance of considering patient history, endoscopic findings, symptom patterns, and potential comorbid conditions such as hypereosinophilic syndrome, celiac disease, or achalasia.